Rhinovirus rampant or testing triumphant?
Biocept's Covid-19 Testing Capacity Puts It at the Head of the Pack
1/3 of parents in 3 states may not send children to school because of COVID-19
Reopening America: How division and vulnerability hamper our response
Week Ahead – Jitters Continue into Busy Week
Expanded unemployment insurance continues to be a crucial lifeline for millions of workers: See updated state unemployment data
Outlook for Latin America and the Caribbean: An Intensifying Pandemic
U.S. sets one-day record for COVID-19 cases, Texas pauses reopening
Florida Reports 9,000 COVID-19 Cases In A Single Day, Smashing Last Record: Live Updates
Coronavirus pharma news roundup – 26/06/20
One coronavirus vaccine stock is up 750% this year. Could the rest follow?
Total US Coronavirus Cases Likely 10x Higher Than Official Tally, CDC Warns
The COVID-19 pandemic can prepare us for future outbreaks and bioterrorism
Here Are The States Goldman Thinks Will Be Forced To Reverse Opening Plans
USask researchers to develop saliva-based COVID-19 home testing kit
Many studies of COVID-19 antibody test accuracy fall short: review
Coronavirus: our study suggests more people have had it than previously estimated
New COVID-19 Cases Soar, But New Deaths Decline As Younger Patients Recover
New sensor may soon test for coronavirus and flu simultaneously
Texas Gov Pauses Economic Reopening As Florida, Arizona Report Latest Batch Of Infections: Virus Updates
Coronavirus weekly: treatments on the horizon and lessons for the next pandemic
Early childhood vaccinations might protect children from COVID-19
Pinewood Atlanta Studios outlines safety measures as it prepares to restart movie and TV production
Coronavirus: asymptomatic people can still develop lung damage
Gene therapy and CRISPR strategies for curing blindness (Yes, you read that right)
COVID-19 and cancer: can pharma stymie the pandemic’s impact on mortality?
NICE green lights Roche’s Rozlytrek for NTRK tumours
BERG taps supercomputer to speed AI discovery of COVID-19 drugs
AstraZeneca taps Scottish firm for 10th COVID-19 vaccine supply deal
Experts identify steps to expand and improve antibody tests in COVID-19 response